Managed Healthcare Executive April 17, 2024
The patients’ lived experience should be an important element in deciding the value of prescription drugs, said speakers at the annual meeting of the Academy of Managed Care Pharmacy.
Sarah K. Emond, MPP, president and CEO of the Institute for Clinical and Economic Review (ICER), said the quiet part out loud: providers and healthcare payers make trade-offs when deciding what drugs to cover and for what patients.
“There is a real tension when making decisions for a particular condition or particular patient population with all the other priorities we have as a healthcare system or as a payer. That tension is real,” Emond said during a session at the annual meeting of the Academy of Managed Care Pharmacy in New...
Today's Sponsors
Today's Sponsor